Lv51
1068 积分 2024-04-22 加入
The evolving landscape of drug targets
9天前
已完结
Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion
1个月前
已完结
SOT201: cis -acting PD-1/IL-15 mutein-based immunocytokine under investigational study in solid tumors
1个月前
已完结
Phase I/Ib study evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of NIZ985 monotherapy and in combination with an anti-PD-1 agent in patients with advanced solid tumors or lymphoma
1个月前
已完结
Cytokines as potential combination agents with PD‐1/PD‐L1 blockade for cancer treatment
1个月前
已完结
A quantitative systems pharmacology model to inform clinical translation of dynamic PKPD relationships of engineered IL-15
1个月前
已完结
IL15/IL15Rα Complex Induces an Antitumor Immune Response following Radiotherapy only in the Absence of Tregs and Fails to Expand Progenitor TCF1+ CD8 T Cells
1个月前
已完结
IL15/IL15Rα Complex Induces an Antitumor Immune Response following Radiotherapy only in the Absence of Tregs and Fails to Expand Progenitor TCF1+ CD8 T Cells
1个月前
已完结
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity
1个月前
已完结
The Common γ-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands
1个月前
已完结
皖公网安备34019202002308
